Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
Children's Hospital of Philadelphia
Children's Hospital Medical Center, Cincinnati
M.D. Anderson Cancer Center
Thomas Jefferson University
Thomas Jefferson University
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
City of Hope Medical Center
City of Hope Medical Center
Thomas Jefferson University
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Cellphire Therapeutics, Inc.
Merck Sharp & Dohme LLC
University of Alabama at Birmingham
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Loyola University
CTI BioPharma
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Boston Children's Hospital
Fred Hutchinson Cancer Center
University of Maryland, Baltimore
University of Arizona
Stanford University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Wake Forest University Health Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Wake Forest University Health Sciences
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Cedars-Sinai Medical Center
Masonic Cancer Center, University of Minnesota
University of California, San Francisco
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Novartis
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
University of Chicago
Hospital Israelita Albert Einstein
National Institutes of Health Clinical Center (CC)
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology